kentucky semaglutide intestinal paralysis lawsuit gastroparesis class action in Ozempic Stomach [2026 Update] kentucky semaglutide stomach paralysis lawsuit

under the brand name Wegovy, for the treatment of adults with a body mass index (BMI) of 30 (obesity) or greater or BMI of 27 (overweight) or greater with at least one weight-related comorbid condition

Janus kinase (JAK) inhibitors represent newer targeted synthetic DMARDs with demonstrated efficacy, though they carry boxed warnings regarding serious infections, malignancy, major adverse cardiovascular events, and thrombosis

You have multiple endocrine neoplasia syndrome type 2 (MEN 2)

Because GLP-1 also has potential anti-inflammatory properties, it can contribute to a healthier gut lining, thus preventing gastrointestinal problems in the long term

Sermorelin supports gradual hormonal balance and improved metabolism over time, while Semaglutide offers more immediate weight loss by reducing appetite and controlling blood sugar levels

However, about 50% of patients continue to have symptoms while receiving H1-antihistamines